Fresenius

Fresenius Medical Care Supports Education for Healthcare Professionals in Korea With the Opening of Its First Training Center

Retrieved on: 
Monday, June 28, 2021
Nursing, Education, Health, Hospitals, General Health, Other Education, Training, Bad Homburg vor der Höhe, Health care, Health, Private providers of NHS services, Fresenius, Health professional, Germany

Certified trainers from Fresenius Medical Care, together with regional clinical education experts from across Asia Pacific, will provide best practice training for healthcare professionals within the renal care field.

Key Points: 
  • Certified trainers from Fresenius Medical Care, together with regional clinical education experts from across Asia Pacific, will provide best practice training for healthcare professionals within the renal care field.
  • With the opening of the Training Center, Fresenius Medical Care Korea pledges its ongoing support of healthcare professional education.
  • The Fresenius Medical Care Training Center also offers educational opportunities catering to individual healthcare professionals specializing in particular treatment modalities such as PD, HD, and CRRT.
  • The Fresenius Medical Care Training Center will provide healthcare professionals with high-standard, systematic training, helping them to advance their knowledge and skills in renal and critical care.

Abbas Hussain Appointed as New Chief Executive Officer of Vifor Pharma

Retrieved on: 
Thursday, June 24, 2021
Biotechnology, Pharmaceutical, Health, Vifor Pharma, Companies, Fresenius, Industry economics), Life sciences

Until Abbas Hussain joins the company on 16 August 2021, Stefan Schulze will continue to have overall executive responsibility for the Vifor Pharma Group.

Key Points: 
  • Until Abbas Hussain joins the company on 16 August 2021, Stefan Schulze will continue to have overall executive responsibility for the Vifor Pharma Group.
  • From 2017 to 2020, he was President of the Executive Committee and Chief Operating Officer (COO) of the Vifor Pharma Group.
  • He joined the Vifor Pharma Group in 2014 as CEO of Vifor Fresenius Medical Care Renal Pharma Ltd.
  • Jacques Theurillat, Chairman of the Board of Directors of Vifor Pharma, commented: We are delighted that Abbas Hussain, an experienced and entrepreneurial leader, will take over the helm of Vifor Pharma.

Vifor Pharma to revise DIAMOND study, readout expected in H2 2021

Retrieved on: 
Thursday, June 24, 2021
Health, Clinical trials, Research, Science, Pharmaceutical, Cardiology, Biotechnology, Vifor Pharma, Bad Homburg vor der Höhe, Companies, Medical specialties, Health care, Fresenius, Hyperkalemia, Vifor Pharma Group, DIAMOND, hyperkalemia, VIFOR PHARMA GROUP, DIAMOND, HYPERKALEMIA

More than 1,000 patients with heart failure and with hyperkalemia or history of hyperkalemia have already been enrolled in DIAMOND.

Key Points: 
  • More than 1,000 patients with heart failure and with hyperkalemia or history of hyperkalemia have already been enrolled in DIAMOND.
  • Following the change of endpoints, study read-out and remaining data collection is expected to be completed in 2021.
  • Vifor Pharma will host a conference call today, 24 June 2021 at 10:30 am (CET).
  • Vifor Pharma Group holds a leading position in all its core business activities and consists of the following companies: Vifor Pharma and Vifor Fresenius Medical Care Renal Pharma (a joint company with Fresenius Medical Care).

Fresenius Kabi Receives Premier Supplier Legacy Award

Retrieved on: 
Monday, June 21, 2021
Medical Supplies, Health, Fitness & Nutrition, General Health, Pharmaceutical, Biotechnology, Bad Homburg vor der Höhe, Fresenius, Societates Europaeae, Germany, Industry economics), Bidiphar

Fresenius Kabi, a global health care company that specializes in medicines and technologies for infusion, transfusion and clinical nutrition, announced today it has received a 2021 Supplier Legacy Award from Premier Inc. ( www.premierinc.com ), a leading health care improvement company.

Key Points: 
  • Fresenius Kabi, a global health care company that specializes in medicines and technologies for infusion, transfusion and clinical nutrition, announced today it has received a 2021 Supplier Legacy Award from Premier Inc. ( www.premierinc.com ), a leading health care improvement company.
  • Fresenius Kabi was recognized for its long-standing support of Premier members through exceptional local customer service and engagement, value creation through clinical excellence and commitment to cost optimizations, according to Premier.
  • Thats why its particularly gratifying to receive this recognition from Premier, said John Ducker, president and CEO of Fresenius Kabi USA.
  • Legacy Award winners have a tenure of more than three years as a Premier contracted supplier.

Women's Health Connecticut Joins CTHealthLink HIE: Partnership Provides Opportunities to Address Racial and Ethnic Disparities in Women's Health

Retrieved on: 
Monday, June 14, 2021
Health, Woonsocket, Rhode Island, Life sciences, Clinic, Health information exchange, CVS Health, Fresenius

Serving nearly 300,000 patients annually across 85 locations, Women's Health Connecticut is the largest provider of obstetrics and gynecology services in the state.

Key Points: 
  • Serving nearly 300,000 patients annually across 85 locations, Women's Health Connecticut is the largest provider of obstetrics and gynecology services in the state.
  • The Connecticut State Medical Society has long been a leader in addressing racial, ethnic, and economic disparities.
  • "As large organizations like Women's Health CT join CTHealthLink, Connecticut moves closer to realizing the promise that health information exchange holds for improving health."
  • Nationally CTHealthLink is connected to CVS Health and Minute Clinics, the Veterans Administration, the Department of Defense, DaVita Health, Fresenius Medical Care and Premise Health.

Humacyte Expands Strategic Global Partnership with Fresenius Medical Care

Retrieved on: 
Friday, June 11, 2021
Medicine, Clinical medicine, Bad Homburg vor der Höhe, Membrane technology, Health care, Renal dialysis, Private providers of NHS services, Fresenius, Societates Europaeae, Laura Niklason, Hemodialysis, Dialysis

Fresenius Medical Care will adopt the HAV as a standard of care in patients who will benefit from clinical and economic perspectives.

Key Points: 
  • Fresenius Medical Care will adopt the HAV as a standard of care in patients who will benefit from clinical and economic perspectives.
  • Under a Distribution Agreement entered into in June 2018, Fresenius Medical Care obtained the exclusive global rights to commercialize Humacytes HAVs in the applications of vascular access for hemodialysis and peripheral arterial disease.
  • We are pleased to expand our partnership with Fresenius Medical Care, the worlds leading care provider for patients undergoing kidney replacement therapy, said Laura Niklason, M.D., Ph.D., Chief Executive Officer of Humacyte.
  • Fresenius Medical Care has a network of more than 4,000 dialysis centers worldwide, and cares for over 300,000 patients with end-stage renal failure.

UConn and CTHealthLink Team to Advance Health Care Analytics

Retrieved on: 
Monday, June 7, 2021
Health informatics, Health information exchange, Life sciences, CVS Health, Biotechnology, Fresenius, Companies

CDAS provides the capabilities to enhance health information sharing and to support sophisticated analytics to yield improved health outcomes and cost efficiencies.

Key Points: 
  • CDAS provides the capabilities to enhance health information sharing and to support sophisticated analytics to yield improved health outcomes and cost efficiencies.
  • "Collaborating with CTHealthLink is a natural progression of our mission to foster interprofessional evidence-based practice and advance the health of individuals in our communities."
  • CTHealthLink is part of the KONZA National Network and provides comprehensive health information technology services including health information exchange and data analytics.
  • Nationally CTHealthLink is connected to CVS Health and Minute Clinics, the Veterans Administration, the Department of Defense, DaVita Health, Fresenius Medical Care and Premise Health.

OPKO Health Reports Transfer of Licensed Rights to RAYALDEE® in Japan to Vifor

Retrieved on: 
Monday, May 24, 2021
Bad Homburg vor der Höhe, Secosteroids, Vitamin D, Vifor Pharma, Companies, OPKO Health, Fresenius, Germany, Calcifediol, Calcitriol, Secondary hyperparathyroidism, Health care

MIAMI, May 24, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced a transfer of the licensed rights to RAYALDEE in Japan from Japan Tobacco Inc. (JT) to Vifor Fresenius Medical Care Renal Pharma (VFMCRP).

Key Points: 
  • MIAMI, May 24, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced a transfer of the licensed rights to RAYALDEE in Japan from Japan Tobacco Inc. (JT) to Vifor Fresenius Medical Care Renal Pharma (VFMCRP).
  • RAYALDEE is an extended release formulation of calcifediol, a prohormone of calcitriol, the active form of vitamin D3.
  • RAYALDEE is approved to treat SHPT in adults with stage 3 or 4 CKD and vitamin D insufficiency in the U.S. and 11 European countries.
  • Vifor Fresenius Medical Care Renal Pharma (a joint company with Fresenius Medical Care) is part of the Vifor Pharma Group (VPG), a global pharmaceutical company.

Temsirolimus Injection Now Available from Fresenius Kabi

Retrieved on: 
Friday, May 21, 2021
Research, FDA, Clinical trials, Biotechnology, Other Health, Health, Pharmaceutical, Science, Oncology, Macrolides, Polyenes, Antineoplastic drugs, Temsirolimus, Sirolimus, Fresenius, Health care, Clinical medicine, Medicine, Temsirolimus Injection, Fresenius Kabi, TEMSIROLIMUS INJECTION, FRESENIUS KABI

b"Fresenius Kabi announced today the immediate availability of Temsirolimus Injection in the United States.

Key Points: 
  • b"Fresenius Kabi announced today the immediate availability of Temsirolimus Injection in the United States.
  • Fresenius Kabi\xe2\x80\x99s Temsirolimus Injection is supplied as a kit including one vial of 25 mg/mL Temsirolimus solution and one vial of diluent.\nThis press release features multimedia.
  • View the full release here: https://www.businesswire.com/news/home/20210521005009/en/\nTemsirolimus, for the treatment of renal cancer, is now available in the U.S. from Fresenius Kabi.
  • If alternatives cannot be used, dose modifications of Temsirolimus Injection are recommended.\nThis Important Safety Information does not include all the information needed to use Temsirolimus Injection safely and effectively.

Beyond Air® Strengthens Commercial Leadership Team with Appointments of Head of Sales and Head of Marketing

Retrieved on: 
Thursday, May 20, 2021
Mallinckrodt, Pharmaceutical industry in China, Fresenius, Commercialization, Articles, Companies, Product

She has crafted and led commercialization programs for medical device and pharmaceutical products in global companies, including, most recently, Fresenius Medical Care.

Key Points: 
  • She has crafted and led commercialization programs for medical device and pharmaceutical products in global companies, including, most recently, Fresenius Medical Care.
  • As an industry-recognized sales leader, she recruits, mentors, and develops top talent to develop a world class sales team to maximize opportunity while assuring customer-centricity and focusing on exceptional service.
  • As Head of Sales at Beyond Air, Ms. Van Doren will lead all sales operations for the US.\nKori-Ann Taylor joins Beyond Air as an experienced marketing leader within the healthcare industry.
  • While at Fingerpaint, she was the marketing account lead for the industry nitric oxide leader, under both Ikaria and Mallinckrodt Pharmaceuticals.